Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Spaeth

Showing results (831-840 of 932) with videos related to

Pageof 94
Sort By:
American Journal of Physiology. Endocrinology and Metabolism|November 12, 2015
The MAFB transcription factor impacts islet α-cell function in rodents and represents a unique signature of primate islet β-cellsElizabeth Conrad, Chunhua Dai, Jason Spaeth, et al.
Anticancer Research|July 5, 2020
GINECO Prospective Non-interventional PROSPECTYON Study: Trabectedin Plus Pegylated Liposomal Doxorubicin for Platinum-sensitive Recurrent Ovarian CancerFrÉdÉric Selle, Pierre-Etienne Heudel, Anne-Claire Hardy-Bessard, et al.
The Journal of Biological Chemistry|February 15, 2018
Oncogenic exon 2 mutations in Mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8/19Min Ju Park, Hailian Shen, Jason M Spaeth, et al.
Breast Cancer Research and Treatment|September 14, 2007
A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapyStephen R D Johnston, Vladimir F Semiglazov, George M Manikhas, et al.
Cell Reports|February 20, 2026
Goal-directed learning in cortical organoidsAsh Robbins, Hunter E Schweiger, Sebastian Hernandez, et al.
Clinical Breast Cancer|July 9, 2023
Long Terms Follow-Up of the Randomized MetaspHER Study Comparing Intravenous Versus Subcutaneous Trastuzumab in Patients' With HER2-Positive Metastatic Breast CancerXavier Pivot, Jean-Philippe Spano, Marc Espie, et al.
Plos One|February 11, 2015
Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validationRalf S Eschbach, Wolfgang P Fendler, Philipp M Kazmierczak, et al.
Pediatric Cardiology|May 21, 2015
Sedation and Anesthesia in Pediatric and Congenital Cardiac Catheterization: A Prospective Multicenter ExperienceC Huie Lin, Sanyukta Desai, Ramzi Nicolas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 3, 2005
Gemcitabine-docetaxel versus cisplatin-vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatinJ-L Pujol, J-L Breton, R Gervais, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 7, 2025
Brain outcomes with lifestyle change in adults with Down syndrome: Rationale and design for a 12-month randomized trialLauren T Ptomey, Joseph E Donnelly, Jeffery Burns, et al.
Pageof 94

Showing results (831-840 of 932) with videos related to

Sort By:
Pageof 94
American Journal of Physiology. Endocrinology and Metabolism|November 12, 2015
The MAFB transcription factor impacts islet α-cell function in rodents and represents a unique signature of primate islet β-cellsElizabeth Conrad, Chunhua Dai, Jason Spaeth, et al.
Anticancer Research|July 5, 2020
GINECO Prospective Non-interventional PROSPECTYON Study: Trabectedin Plus Pegylated Liposomal Doxorubicin for Platinum-sensitive Recurrent Ovarian CancerFrÉdÉric Selle, Pierre-Etienne Heudel, Anne-Claire Hardy-Bessard, et al.
The Journal of Biological Chemistry|February 15, 2018
Oncogenic exon 2 mutations in Mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8/19Min Ju Park, Hailian Shen, Jason M Spaeth, et al.
Breast Cancer Research and Treatment|September 14, 2007
A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapyStephen R D Johnston, Vladimir F Semiglazov, George M Manikhas, et al.
Cell Reports|February 20, 2026
Goal-directed learning in cortical organoidsAsh Robbins, Hunter E Schweiger, Sebastian Hernandez, et al.
Clinical Breast Cancer|July 9, 2023
Long Terms Follow-Up of the Randomized MetaspHER Study Comparing Intravenous Versus Subcutaneous Trastuzumab in Patients' With HER2-Positive Metastatic Breast CancerXavier Pivot, Jean-Philippe Spano, Marc Espie, et al.
Plos One|February 11, 2015
Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validationRalf S Eschbach, Wolfgang P Fendler, Philipp M Kazmierczak, et al.
Pediatric Cardiology|May 21, 2015
Sedation and Anesthesia in Pediatric and Congenital Cardiac Catheterization: A Prospective Multicenter ExperienceC Huie Lin, Sanyukta Desai, Ramzi Nicolas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 3, 2005
Gemcitabine-docetaxel versus cisplatin-vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatinJ-L Pujol, J-L Breton, R Gervais, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 7, 2025
Brain outcomes with lifestyle change in adults with Down syndrome: Rationale and design for a 12-month randomized trialLauren T Ptomey, Joseph E Donnelly, Jeffery Burns, et al.
Pageof 94